Presenteeism in inflammatory bowel diseases: A hidden problem with significant economic impact

Inflammatory Bowel Diseases

Volumn 21, Issue 7, 2015, Pages 1623-1630

  Zand, Aria ^a,b   Van Deen, Welmoed K ^a   Inserra, Elizabeth K ^a   Hall, Laurin ^a   Kane, Ellen ^a   Centeno, Adriana ^a   Choi, Jennifer M ^a   Ha, Christina Y ^a   Esrailian, Eric ^a   D'haens, Geert R ^b   Hommes, Daniel W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

indirect costs; presenteeism; productivity; work related problems

Indexed keywords

ADULT; AGED; ARTICLE; COMPENSATION; CONTROLLED STUDY; EMPLOYMENT; FATIGUE; FEMALE; HEALTH CARE COST; HUMAN; INFLAMMATORY BOWEL DISEASE; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MOTIVATION; PRESENTEEISM; PRIORITY JOURNAL; PRODUCTIVITY; PROSPECTIVE STUDY; REMISSION; UNEMPLOYMENT; WORK; ADOLESCENT; COST OF ILLNESS; ECONOMICS; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COST OF ILLNESS; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; PRESENTEEISM; PROSPECTIVE STUDIES; QUALITY OF LIFE; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84932092328     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000399     Document Type: Article

References (32)

1. Busch K, da Silva SA, Holton M, et al. Sick leave and disability pension in inflammatory bowel disease: a systematic review. J Crohns Colitis. 2014;8:1362-1377.
2. Hemp P. Presenteeism: at work-but out of it. Harv Bus Rev. 2004;82:49-58, 155.
3. Hommes D, Colombel JF, Emery P, et al. Changing Crohn's disease management: need for new goals and indices to prevent disability and improve quality of life. J Crohns Colitis. 2012;6(suppl 2):S224-S234.
4. Kappelman MD, Rifas-Shiman SL, Kleinman K, et al. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol. 2007;5:1424-1429.
5. Bernklev T, Jahnsen J, Henriksen M, et al. Relationship between sick leave, unemployment, disability, and health-related quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2006;12:402-412.
6. Boonen A, Dagnelie PC, Feleus A, et al. The impact of inflammatory bowel disease on labor force participation: results of a population sampled case-control study. Inflamm Bowel Dis. 2002;8:382-389.
7. Calsbeek H, Rijken M, Dekker J, et al. Disease characteristics as determinants of the labour market position of adolescents and young adults with chronic digestive disorders. Eur J Gastroenterol Hepatol. 2006;18:203-209.
8. Mayberry JF. Impact of inflammatory bowel disease on educational achievements and work prospects. J Pediatr Gastroenterol Nutr. 1999; 28:S34-S36.
9. Magro F, Portela F, Lago P, et al. Inflammatory bowel disease: a patient's and caregiver's perspective. Dig Dis Sci. 2009;54:2671-2679.
10. Longobardi T, Jacobs P, Bernstein CN. Work losses related to inflammatory bowel disease in the United States: results from the National Health Interview Survey. Am J Gastroenterol. 2003;98:1064-1072.
11. Lonnfors S, Vermeire S, Greco M, et al. IBD and health-related quality of life-discovering the true impact. J Crohns Colitis. 2014;8;1281-1286.
12. Jacobs P, Bissonnette R, Guenther LC. Socioeconomic burden of immune-mediated inflammatory diseases-focusing on work productivity and disability. J Rheumatol Suppl. 2011;88:55-61.
13. Binion DG, Louis E, Oldenburg B, et al. Effect of adalimumab on work productivity and indirect costs in moderate to severe Crohn's disease: a meta-Analysis. Can J Gastroenterol. 2011;25:492-496.
14. Reinisch W, Sandborn WJ, Bala M, et al. Response and remission are associated with improved quality of life, employment and disability status, hours worked, and productivity of patients with ulcerative colitis. Inflamm Bowel Dis. 2007;13:1135-1140.
15. Feagan BG, Reilly MC, Gerlier L, et al. Clinical trial: the effects of certolizumab pegol therapy on work productivity in patients with moderate-To-severe Crohn's disease in the PRECiSE 2 study. Aliment Pharmacol Ther. 2010;31:1276-1285.
16. Everhart JE, Ruhl CE. Burden of digestive diseases in the United States part I: overall and upper gastrointestinal diseases. Gastroenterology. 2009; 136:376-386.
17. Gibson TB, Ng E, Ozminkowski RJ, et al. The direct and indirect cost burden of Crohn's disease and ulcerative colitis. J Occup Environ Med. 2008;50:1261-1272.
18. Gunnarsson C, Chen J, Rizzo JA, et al. The employee absenteeism costs of inflammatory bowel disease: evidence from US National Survey Data. J Occup Environ Med. 2013;55:393-401.
19. Sandler RS, Everhart JE, Donowitz M, et al. The burden of selected digestive diseases in the United States. Gastroenterology. 2002;122: 1500-1511.
20. Porter ME, Teisberg EO. Redefining Health Care: Creating Value-based Competition on Results. Boston, MA: Harvard Business School Press; 2006.
21. Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4:353-365.
22. Irvine EJ, Zhou Q, Thompson AK. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial. Am J Gastroenterol. 1996;91:1571-1578.
23. Harvey RF, Bradshaw JM. A simple index of Crohn's-disease activity. Lancet. 1980;1:514.
24. Lewis JD, Chuai S, Nessel L, et al. Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis. Inflamm Bowel Dis. 2008;14:1660-1666.
25. Labor USDo. Employer Costs for Employee compensation: June 2014. Washington, DC: Bureau of Labor Statistics; 2014.
26. Berger ML, Murray JF, Xu J, et al. Alternative valuations of work loss and productivity. J Occup Environ Med. 2001;43:18-24.
27. Nicholson S, Pauly MV, Polsky D, et al. Measuring the effects of work loss on productivity with team production. Health Econ. 2006;15:111-123.
28. Disease PtFC, Alliance USWW. The Burden of Chronic Disease on Business and U.S. Competitiveness: Excerpt from the 2009 Almanac of Chronic Disease: Partnership to Fight Chronic Disease; Atlanta, GA; 2009.
29. Lichtenstein GR, Yan S, Bala M, et al. Remission in patients with Crohn's disease is associated with improvement in employment and quality of life and a decrease in hospitalizations and surgeries. Am J Gastroenterol. 2004;99:91-96.
30. Mandel MD, Balint A, Lovasz BD, et al. Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics. Eur J Health Econ. 2014;15(suppl 1):S121-S128.
31. Stroupe KT, Kinney ED, Kniesner JJ. Chronic illness and health insurance-related job lock. J Policy Anal Manage. 2001;20:525-544.
32. Siu AM, Hung A, Lam AY, et al. Work limitations, workplace concerns, and job satisfaction of persons with chronic disease. Work. 2013;45: 107-115.